Sur, D., Havasi, A., Lungulescu, C., Volovat, S., Burz, C. and Irimie, A. (2022) “Endoglin (CD105) as a putative prognostic biomarker for colorectal cancer: a systematic review”, Medicine and Pharmacy Reports. doi: 10.15386/mpr-2120.